University of Oxford
1,169
124
187
695
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.3%
62 terminated/withdrawn out of 1169 trials
91.8%
+5.3% vs industry average
11%
131 trials in Phase 3/4
12%
83 of 695 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1169)
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency
Role: collaborator
VRehab-SMA Phase 1.2
Role: lead
A Remote Study Using Technology to Assess Outcomes in DMD
Role: lead
Gut Leakage' in Dengue
Role: lead
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Role: collaborator
Vaginal Fluid Derived Biomarkers in the Early Detection and Evolution of Gynaecological Cancers
Role: collaborator
Parenting in the Preschool System in Malaysia
Role: lead
Inflammation Digital Biomarkers Validation Study
Role: lead
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Role: collaborator
SCOOT: Sample Collection for DART
Role: lead
Preparing for Maternal GBS Vaccine Trials in Africa
Role: collaborator
Unrecognised Comorbidity Detection in Hospitalised Patients
Role: lead
Tracking Atrial Fibrillation After Intensive Care Admission
Role: lead
Pilot Factorial Trial in Malaysia
Role: lead
Probiotic Intake and Perimenopausal Psychological Assessments
Role: lead
Predictors Of Cognitive Decline Using Digital Devices
Role: collaborator
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
Role: collaborator
A Study of Digital Cognitive Behavioural Therapy for Insomnia in Fibromyalgia
Role: lead
A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21
Role: lead
Blood Lipid Responses to Diet Macronutrients
Role: lead